Total Payments
$300,202
2024 Payments
$14,052
Companies
15
Transactions
266
Medicare Patients
745
Medicare Billing
$88,962
Payment Breakdown by Category
Other$208,827 (69.6%)
Consulting$61,550 (20.5%)
Food & Beverage$16,654 (5.5%)
Travel$12,971 (4.3%)
Education$199.50 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,827 | 17 | 69.6% |
| Consulting Fee | $61,550 | 19 | 20.5% |
| Food and Beverage | $16,654 | 203 | 5.5% |
| Travel and Lodging | $12,971 | 24 | 4.3% |
| Education | $199.50 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumenis BE inc | $111,177 | 4 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $82,528 | 136 | $0 (2024) |
| Lumenis, Inc | $55,840 | 3 | $0 (2020) |
| Galderma Laboratories, L.P. | $47,679 | 49 | $0 (2024) |
| Merz Pharmaceuticals GmbH | $1,314 | 19 | $0 (2017) |
| Allergan, Inc. | $688.15 | 37 | $0 (2022) |
| Solta Medical, a division of Bausch Health US, LLC | $403.95 | 5 | $0 (2020) |
| ABBVIE INC. | $338.00 | 1 | $0 (2024) |
| PFIZER INC. | $77.83 | 4 | $0 (2021) |
| Medimetriks Pharmaceuticals, Inc. | $56.40 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,052 | 11 | Galderma Laboratories, L.P. ($6,831) |
| 2023 | $83,062 | 20 | Lumenis BE inc ($72,609) |
| 2022 | $31,539 | 32 | Lumenis BE inc ($27,053) |
| 2021 | $26,594 | 38 | Galderma Laboratories, L.P. ($18,520) |
| 2020 | $28,262 | 27 | Galderma Laboratories, L.P. ($14,835) |
| 2019 | $42,357 | 63 | Merz North America, Inc. ($24,305) |
| 2018 | $71,740 | 40 | Merz North America, Inc. ($43,152) |
| 2017 | $2,595 | 35 | Merz Pharmaceuticals GmbH ($1,314) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $338.00 | General |
| 06/28/2024 | Galderma Laboratories, L.P. | — | Consulting Fee | Cash or cash equivalent | $2,205.00 | General |
| 06/01/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $124.51 | General |
| Category: Dermatology | ||||||
| 05/21/2024 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| 05/08/2024 | MERZ NORTH AMERICA, INC. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $101.02 | General |
| Category: Dermatology | ||||||
| 04/30/2024 | Lumenis BE inc | Optilight (Device) | Food and Beverage | Cash or cash equivalent | $6,514.65 | General |
| Category: Opthamology | ||||||
| 04/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 04/25/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $22.90 | General |
| 04/03/2024 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | In-kind items and services | $143.33 | General |
| 03/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.09 | General |
| 02/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $33.88 | General |
| 12/20/2023 | Lumenis BE inc | M22 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $72,608.94 | General |
| Category: Dermathology | ||||||
| 12/19/2023 | Galderma Laboratories, L.P. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,375.00 | General |
| 12/19/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Dermatology | ||||||
| 12/19/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Dermatology | ||||||
| 11/29/2023 | Merz North America, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,175.00 | General |
| 11/09/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $83.87 | General |
| Category: Dermatology | ||||||
| 10/27/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $141.01 | General |
| Category: Musculoskeletal | ||||||
| 10/24/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.41 | General |
| 10/18/2023 | Merz North America, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,915.00 | General |
| 09/25/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $8.01 | General |
| 08/26/2023 | Galderma Laboratories, L.P. | DYSPORT | Food and Beverage | In-kind items and services | $88.17 | General |
| 08/09/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Musculoskeletal | ||||||
| 06/21/2023 | Merz North America, Inc. | Xeomin | Food and Beverage | In-kind items and services | $172.19 | General |
| 05/03/2023 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $24.80 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 187 | 371 | $33,320 | $19,056 |
| 2022 | 7 | 180 | 337 | $41,308 | $21,900 |
| 2021 | 10 | 277 | 477 | $69,155 | $35,644 |
| 2020 | 4 | 101 | 175 | $54,809 | $12,362 |
Total Patients
745
Total Services
1,360
Medicare Billing
$88,962
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 128 | $15,176 | $9,026 | 59.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 35 | $6,008 | $3,335 | 55.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 32 | 39 | $5,030 | $3,125 | 62.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 31 | 47 | $4,640 | $2,119 | 45.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 19 | $1,462 | $847.59 | 58.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 19 | 103 | $1,004 | $603.20 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 138 | $15,743 | $8,714 | 55.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 22 | 38 | $9,411 | $5,620 | 59.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 30 | 36 | $4,958 | $2,611 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 23 | $3,966 | $2,344 | 59.1% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 12 | 14 | $2,218 | $1,210 | 54.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 20 | 28 | $2,876 | $1,072 | 37.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 11 | 60 | $2,136 | $327.97 | 15.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 94 | 186 | $27,597 | $13,517 | 49.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 25 | 43 | $12,710 | $6,462 | 50.8% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 36 | 46 | $6,775 | $3,594 | 53.0% |
| 10061 | Drainage of multiple abscess | Office | 2021 | 19 | 20 | $6,272 | $3,584 | 57.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 26 | $4,135 | $2,810 | 68.0% |
| 10060 | Drainage of abscess | Office | 2021 | 20 | 20 | $3,249 | $2,044 | 62.9% |
| 17000 | Destruction of skin growth | Office | 2021 | 19 | 28 | $2,958 | $1,308 | 44.2% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 13 | 20 | $1,663 | $972.95 | 58.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,503 | $909.54 | 36.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 16 | 76 | $1,294 | $442.78 | 34.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 55 | 108 | $24,373 | $5,913 | 24.3% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 17 | 30 | $23,149 | $4,186 | 18.1% |
About Dr. Amy Lewis, M.D
Dr. Amy Lewis, M.D is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962570093.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Lewis, M.D has received a total of $300,202 in payments from pharmaceutical and medical device companies, with $14,052 received in 2024. These payments were reported across 266 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($208,827).
As a Medicare-enrolled provider, Lewis has provided services to 745 Medicare beneficiaries, totaling 1,360 services with total Medicare billing of $88,962. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 11/30/2006
- Last Updated 10/04/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962570093
Products in Payments
- M22 (Device) $104,662
- XEOMIN (Biological) $8,636
- Optilight (Device) $6,515
- Xeomin (Biological) $5,555
- BOTOX (Biological) $328.00
- BOTOX COSMETIC (Biological) $208.71
- EUCRISA (Drug) $77.83
- Neo-Synalar Cream (Drug) $56.40
- SOOLANTRA (Drug) $33.33
- ENSTILAR (Drug) $26.65
- OPZELURA (Drug) $21.58
- Veltin (Drug) $20.51
- BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device) $19.39
- Rubraca (Drug) $11.33
- KYBELLA (Biological) $9.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dermatology $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M